Medicine
Glycopyrrolate 2 mg tablet
Glycopyrrolate 2 mg tablet is a generic prescription medicine for oral use, made by 13 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Glycopyrrolate
- Brand
- Sold under the generic name
- Strength
- 2 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 60 tablets, 1000 tablets and 30 more
- Manufacturers
- Alembic PharmaceuticalsIndiaAurolife PharmaIndiaAvet PharmaceuticalsIndiaBryant Ranch PrepackRemedyrepackQuagen PharmaceuticalsRising Pharma HoldingsChartwell RXFlorida Pharmaceutical ProductsGolden State Medical Supply
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A03AB02 Glycopyrrolate
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 26 September 2006
- Identifiers
- RxCUI 197739, 197738DailyMed set ID 098c7654-a352-47ee-bf23-6a81f8601266, 33bbc475-2fe3-48ab-8a9d-56d13053593e, db178372-51d2-4194-bbe2-da9acb1cfd53 +16NDC 71335-2720, 72162-1478, 15955-318 +17Application ANDA202675, ANDA040653, ANDA203657 +5
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle, plastic | 15955-318-01 | Alembic PharmaceuticalsIndia | 19 October 2012 |
| 100 tablet in 1 bottle | 13107-015-01 | Aurolife PharmaIndia | 28 February 2023 |
| 100 tablet in 1 bottle | 23155-607-01 | Avet PharmaceuticalsIndia | 27 February 2017 |
| 60 tablet in 1 bottle | 62135-735-60 | Chartwell RX | 15 August 2023 |
| 100 tablet in 1 bottle | 71921-111-01 | Florida Pharmaceutical Products | 12 February 2026 |
| 100 tablet in 1 bottle | 69315-140-01 | Leading Pharma | 22 September 2018 |
| 100 tablet in 1 bottle | 49884-066-01 | Par Health | 26 September 2006 |
| 100 tablet in 1 bottle, plastic | 70752-109-10 | Quagen Pharmaceuticals | 10 October 2024 |
| 1000 tablet in 1 bottle, plastic | 70752-109-11 | Quagen Pharmaceuticals | 10 October 2024 |
| 100 tablet in 1 bottle | 69076-476-01 | Quinn Pharmaceuticals | 1 May 2021 |
| 30 tablet in 1 container | 16571-744-03 | Rising Pharma Holdings | 6 October 2020 |
| 90 tablet in 1 container | 16571-744-09 | Rising Pharma Holdings | 6 October 2020 |
| 100 tablet in 1 bottle | 63629-2207-1 | Bryant Ranch Prepack | 9 October 2024 |
| 30 tablet in 1 bottle | 71335-1225-1 | Bryant Ranch Prepack | 28 December 2021 |
| 90 tablet in 1 bottle | 71335-1225-2 | Bryant Ranch Prepack | 28 December 2021 |
| 28 tablet in 1 bottle | 71335-1225-3 | Bryant Ranch Prepack | 28 December 2021 |
| 18 tablet in 1 bottle | 71335-1225-4 | Bryant Ranch Prepack | 28 December 2021 |
| 30 tablet in 1 bottle | 71335-2119-1 | Bryant Ranch Prepack | 4 October 2024 |
| 90 tablet in 1 bottle | 71335-2119-2 | Bryant Ranch Prepack | 4 October 2024 |
| 28 tablet in 1 bottle | 71335-2119-3 | Bryant Ranch Prepack | 4 October 2024 |
| 18 tablet in 1 bottle | 71335-2119-4 | Bryant Ranch Prepack | 4 October 2024 |
| 14 tablet in 1 bottle | 71335-2119-5 | Bryant Ranch Prepack | 4 October 2024 |
| 30 tablet in 1 bottle | 71335-2720-1 | Bryant Ranch Prepack | 26 September 2025 |
| 90 tablet in 1 bottle | 71335-2720-2 | Bryant Ranch Prepack | 26 September 2025 |
| 28 tablet in 1 bottle | 71335-2720-3 | Bryant Ranch Prepack | 26 September 2025 |
| 18 tablet in 1 bottle | 71335-2720-4 | Bryant Ranch Prepack | 26 September 2025 |
| 14 tablet in 1 bottle | 71335-2720-5 | Bryant Ranch Prepack | 26 September 2025 |
| 100 tablet in 1 bottle | 72162-1478-1 | Bryant Ranch Prepack | 4 October 2024 |
| 100 tablet in 1 bottle | 72162-2598-1 | Bryant Ranch Prepack | 7 January 2026 |
| 100 pouch in 1 box / 1 tablet in 1 pouch | 70518-3031-0 | Remedyrepack | 25 February 2021 |
| 100 pouch in 1 box / 1 tablet in 1 pouch | 70518-4537-0 | Remedyrepack | 17 December 2025 |
| 100 pouch in 1 box / 1 tablet in 1 pouch | 70518-4671-0 | Remedyrepack | 1 June 2026 |
| 100 tablet in 1 bottle | 60429-666-01 | Golden State Medical Supply | 3 February 2016 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 11 August 1961 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Glycopyrrolate
Clinical summary
Glycopyrrolate is an anticholinergic indicated in adults to reduce symptoms of a peptic ulcer as an adjunct to treatment of peptic ulcer, among other approved uses. MedsAcross supplies Glycopyrrolate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about GlycopyrrolateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Glycopyrrolate prescribing information (Rising Pharma Holdings) · U.S. National Library of Medicine, DailyMed
Need Glycopyrrolate 2 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.